Citicoline preclinical and clinical update 2009-2010

38Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Citicoline is a neuroprotectant and neurorestorative drug that is used in the treatment of acute ischemic stroke in some countries. The research with this compound continues. In this review, we focus on the latest publications or communications or both and on the major ongoing experimental and clinical projects involving citicoline in stroke recovery. © 2010 American Heart Association, Inc.

References Powered by Scopus

Lipid oxidation and peroxidation in CNS Health and disease: From molecular mechanisms to therapeutic opportunities

403Citations
N/AReaders
Get full text

Role of lipids in brain injury and diseases

223Citations
N/AReaders
Get full text

The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome

213Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Neuroprotection for ischaemic stroke: Current status and challenges

205Citations
N/AReaders
Get full text

Guidelines for the treatment of acute ischaemic stroke

104Citations
N/AReaders
Get full text

Pivotal role of choline metabolites in remyelination

80Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Dávalos, A., & Secades, J. (2011). Citicoline preclinical and clinical update 2009-2010. In Stroke (Vol. 42). https://doi.org/10.1161/STROKEAHA.110.605568

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

43%

Professor / Associate Prof. 11

37%

Researcher 5

17%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 18

60%

Agricultural and Biological Sciences 5

17%

Pharmacology, Toxicology and Pharmaceut... 4

13%

Neuroscience 3

10%

Save time finding and organizing research with Mendeley

Sign up for free